Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib:A Prospective, Single-arm, Multicenter, Observational Study
This document provides an update on a prospective, single-arm observational trial evaluating E-TACE in combination with donafenib for unrese…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization [NA]
A clinical trial update on evaluating Antrodia Cinnamomea in hepatocellular carcinoma patients after transarterial chemoembolization, curren…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB [Phase 4]
Phase 4 clinical trial investigating postoperative adjuvant therapy for hepatocellular carcinoma patients with positive TB; the trial is not…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCI-sponsored prospective study aims to procure tumor tissue to identify novel therapeutic targets and study the tumor microenvironment; enr…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Effect of the HCC Liver-Link Intervention [NA]
Clinical trial update on the HCC Liver-Link Intervention, currently recruiting for hepatocellular carcinoma with a focus on racial dispariti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prehabilitation and Posttransplant Training Program in Liver Transplantation [NA]
This clinical trial update describes a prehabilitation and posttransplant training program for patients undergoing liver transplantation, cu…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Organoid Models of Hepatocellular Carcinoma [NA]
A clinical trial sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS is investigating organoid models of hepatocellular…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
An observational study conducted by The First Affiliated Hospital of Zhengzhou University aims to reduce the risk of liver cancer in people …
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
A clinical trial evaluating computer-aided diagnosis for detecting microvascular invasion in hepatocellular carcinoma, sponsored by the Chin…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Molecular Basis of Pediatric Liver Cancer
University of Pittsburgh sponsors a recruiting study on the molecular basis of pediatric liver cancer, evaluating several liver tumor types …
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment [Phase 2]
A Phase 2 trial is exploring partial immune-boosted TACE for unresectable hepatocellular carcinoma in patients receiving systemic treatment.…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC [Phase 2]
Phase 2 clinical trial evaluating proton radiotherapy in combination with tremelimumab and durvalumab for intermediate-to-advanced hepatocel…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors
Prospective cohort study assessing the use of thermal ablation for malignant liver tumors, currently recruiting at Leiden University Medical…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Hepatocellular Carcinoma Identification Using Delta-HLD
A clinical trial update notes a study evaluating Delta-HLD for identification of hepatocellular carcinoma, which is currently recruiting and…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors [NA]
Clinical trial update on multimodal thermal therapy for malignant liver tumors, evaluating safety, efficacy, and immune response in hepatoce…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Risk Assessment for HBV-Related Liver Cancer
A recruiting clinical trial studying risk assessment for HBV-related liver cancer in patients with HBV-related liver cirrhosis.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: EGCG for Hepatocellular Carcinoma Chemoprevention [Phase 2]
A Phase 2 clinical trial is evaluating epigallocatechin gallate (EGCG) for chemoprevention of hepatocellular carcinoma in patients with cirr…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
This clinical trial update outlines a multi-center real-world study evaluating heterogeneity in efficacy of interventional therapy combined …
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating a triple combination of gecacitinib, donafenib, and a PD-1 inhibitor as an immune rechallenge therapy for …
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Apatinib Mesylate and Camrelizumab Combined With TACE as Neoadjuvant Therapy for Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating apatinib mesylate plus camrelizumab with transarterial chemoembolization as neoadjuvant therapy for hepatocellular …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy [Phase 3]
Phase 3 trial evaluating TPST-1120 in combination with atezolizumab and bevacizumab for unresectable or metastatic hepatocellular carcinoma …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
This entry reports an ongoing Phase 1/2 clinical trial evaluating multi-target Hi-TCR-T cell therapy for advanced hepatocellular carcinoma, …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Unravelling the Impact of Radiofrecuency in Liver Surgery: the Key to Decrease Local Recurrence? [NA]
A clinical trial from Hospital del Mar is investigating the impact of radiofrequency in liver surgery on reducing local recurrence in liver …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)
A clinical trial at Tongji Hospital is evaluating an AI-based model to predict recurrence patterns of hepatocellular carcinoma after liver r…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of SON-DP in participants with relapsed/refractory solid tumors intolerant to standard therapies, including gastric cancer and…